Treatment for Rapid Heartbeat

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Rapid Heartbeat+1 More
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is to study the effects of different drugs on people with a syndrome that causes symptoms like a fast heart rate, fatigue, and dizziness when standing up.

Eligible Conditions
  • Rapid Heartbeat
  • Postural Orthostatic Tachycardia Syndrome (POTS)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 3 hours

1 day
Physiological abnormalities in orthostatic intolerance
blood volume
1 hour
intrinsic heart rate
2 hours
quantitative sweat testing
3 hours
norepinephrine spillover
residual sympathetic function after pharmacological autonomic blockade

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

100 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 hours

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,440 Previous Clinical Trials
24,567,287 Total Patients Enrolled
Satish R. RajLead Sponsor
6 Previous Clinical Trials
430 Total Patients Enrolled
David Robertson, MDPrincipal InvestigatorVanderbilt University
3 Previous Clinical Trials
138 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: